Zhdanov Sergei Vyacheslavovich

Career

2007-2015

Sergei Zhdanov began his career in Sberbank in 2007 as a client manager in the corporate business. Subsequently, he worked in the investment and project financing divisions, headed the Business Development Center.

2015-2020

In 2015-2020, he was transferred Sberbank Europe to Vienna, where he coordinated CIB's large corporate clients by country European Union and CIS. Since 2020, he worked at the Sberbank Health Industry Center as executive director.

2022: Appointment as Managing Director of the Sberbank Health Industry Center

In September 2022, it became known about the appointment of Sergei Zhdanov as managing director of the managing director of the Sberbank Health Industry Center. In addition, he became the general director of a subsidiary of Immunotechnologies LLC.

This appointment was reported by the Pharmaceutical Bulletin, citing its sources on the market, as well as information confirmed by Sberbank.

Sergei Zhdanov has been appointed as the new Managing Director, Director of the Sberbank Health Industry Center.

Earlier in 2022, Vice President and Industry Leader health care Sberbank Yuri Krestinsky left the company of his own free will and decided to continue his career "outside Sberbank."

Krestinsky told the Pharmaceutical Bulletin that some of the features of a large state-owned company created difficulties in management and risks, "which I would not like to face and which I did not want to share."

Having analyzed for myself all the pros and cons, outside and in connection with the latest events in the country and the world, I decided to continue my career outside Sberbank, "Krestinsky summed up. At the same time, he remained chairman of the board of the Bionika group of companies[1]

Notes